Incyte Biosciences Luxembourg Overview

  • Status
  • Acquired/​Merged
  • Employees
  • 135
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Incyte Biosciences Luxembourg General Information

Description

Manufacturer of drugs for cancer treatment. The division is based in Europe and is engaged in manufacturing and marketing of the drug ponatinib (Iclusig). The drug is used for treatment of blood cancers.

Contact Information

Formerly Known As
Ariad Pharmaceuticals (Luxembourg)
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Primary Office
  • Route de la Corniche 1
  • Epalinges
  • 1066 Lausanne
  • Switzerland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Incyte Biosciences Luxembourg Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Incyte Biosciences Luxembourg‘s full profile, request access.

Request a free trial

Incyte Biosciences Luxembourg Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Incyte Biosciences Luxembourg Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Incyte Biosciences Luxembourg‘s full profile, request access.

Request a free trial